These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 11474836)

  • 1. Diabetic nephropathy.
    Boner G; Cooper ME
    Diabetes Technol Ther; 1999; 1(4):489-96. PubMed ID: 11474836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promotion, prediction and prevention of progression of nephropathy in type 1 diabetes mellitus.
    Rossing P
    Diabet Med; 1998 Nov; 15(11):900-19. PubMed ID: 9827844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antihypertensive treatment in type 1 diabetes and diabetic nephropathy].
    Chantrel F; Kolb I; Bouiller M; Hannedouche T
    Nephrologie; 1999; 20(4):203-8. PubMed ID: 10480152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypertension, microalbuminuria and insulin resistance in diabetes mellitus].
    Bretzel RG
    Wien Klin Wochenschr; 1994; 106(24):774-92. PubMed ID: 7846897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antihypertensive treatment in type II diabetes and diabetic nephropathy].
    Chantrel F; Bouiller M; Kolb I; Hannedouche T
    Nephrologie; 2000; 21(2):47-55. PubMed ID: 10798204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk and prevention of diabetic nephropathy].
    Ravera M; Re M; Deferrari G
    G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of blood glucose and blood pressure control on progression of diabetic nephropathy].
    Schwarz C; Oberbauer R
    Wien Klin Wochenschr; 2000 Nov; 112(21):907-11. PubMed ID: 11144004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypertension and diabetes: mechanisms of elevation of arterial pressure, physiopathologic basis of therapeutic antihypertensives].
    Mogensen CE
    Journ Annu Diabetol Hotel Dieu; 1993; ():161-88. PubMed ID: 8331863
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes.
    Nosadini R; Brocco E
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():1-7. PubMed ID: 9288531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diabetic nephropathy].
    Agardh CD
    Nord Med; 1992; 107(8-9):215-6. PubMed ID: 1408727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium-glucose cotransporter 2 inhibition in type 1 diabetes: simultaneous glucose lowering and renal protection?
    Cherney DZ; Perkins BA
    Can J Diabetes; 2014 Oct; 38(5):356-63. PubMed ID: 25192954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [What do large clinical trials learn us about cardiovascular and renal prevention in patients with type 2 diabetes mellitus and hypertension?].
    Dussol B; Berland Y
    Nephrol Ther; 2006 May; 2(2):51-74. PubMed ID: 16895717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The kidney as a target organ in diabetic patients with arterial hypertension].
    Viberti G
    Drugs; 2003; 63 Spec No 1():31-7. PubMed ID: 12708880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thailand diabetes registry project: prevalence, characteristics and treatment of patients with diabetic nephropathy.
    Ngarmukos C; Bunnag P; Kosachunhanun N; Krittiyawong S; Leelawatana R; Prathipanawatr T; Plengvidhya N; Benjasuratwong Y; Suwanwalaikorn S; Deerochanawong C; Chetthakul T; Mongkolsomlit S; Rawdaree P
    J Med Assoc Thai; 2006 Aug; 89 Suppl 1():S37-42. PubMed ID: 17715832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the course to end-stage renal disease of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic nephropathy.
    Pugh JA; Medina R; Ramirez M
    Diabetologia; 1993 Oct; 36(10):1094-8. PubMed ID: 8243860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant macro and microvascular complications in diabetic nephropathy.
    Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypertension and diabetes mellitus].
    Janka HU
    Z Gesamte Inn Med; 1993 Mar; 48(3):157-61. PubMed ID: 8475640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of losartan on renal and cardiovascular complications of patients with type 2 diabetes and nephropathy].
    Parving HH; Brenner BM; Cooper ME; de Zeeuw D; Keane WF; Mitch WE; Remuzzi G; Snapinn SM; Zhang Z; Shahinfar S
    Ugeskr Laeger; 2001 Oct; 163(40):5514-9. PubMed ID: 11601117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current therapeutic management of diabetic nephropathy.
    Kohler SM; Krämer BK
    Acta Diabetol; 1994 Sep; 31(3):119-25. PubMed ID: 7827347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When to treat the hypertensive diabetic patient.
    Fuller JH
    J Diabetes Complications; 1996; 10(3):144-5. PubMed ID: 8807461
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.